Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study

Abstract

Background Nested case-control studies examining the association between serum markers of chronic inflammation, focused on three specific biomarkers (CRP, IL-8 and TNF-α), and risk of pancreatic cancer have reported no associations. In this study, we evaluated associations between standard pre-diagnostic serum markers of chronic inflammation (CRP, albumin, haptoglobin and leukocytes) and pancreatic cancer risk in the Swedish Apolipoprotein-related MORtality RISk (AMORIS) prospective cohort study. Methods We selected all participants (≥20 years old) with baseline measurements of CRP, albumin, haptoglobin and leukocytes between 1985 and 1996 ( n = 61,597). Participants were excluded if they had a history of chronic pancreatitis and all individuals were free from pancreatic cancer at baseline. Cox proportional multivariable hazards regression analysis was carried out for medical cut-offs of CRP, albumin, haptoglobin and leukocytes. Results We observed an increased risk of pancreatic cancer for those individuals with higher levels of serum haptoglobin (≥1.4 g/L), CRP (≥10 mg/L) and leukocytes (≥10 × 10 9 cells/L) compared to those with haptoglobin levels < 1.4 g/L, CRP levels < 10 mg/L and Leukocyte levels < 10 × 10 9 cells/L [haptoglobin HR: 2.23 (95% CI 1.72–2.88), CRP HR: 1.32 (95% CI 1.00–1.74), leukocytes HR: 2.20 (95% CI 1.52–3.18)]. No associations were noted for serum albumin. Conclusions We found an increased risk of pancreatic cancer associated with pre-diagnostic serum levels of haptoglobin, CRP and leukocytes. Our finding suggests a possible role of chronic inflammation in the aetiology of pancreatic cancer and highlight the need to further investigate this association.

Dehydroepiandrosterone modulates oxidative DNA damage in pancreatic cancer: A case–control study

“…Pancreatic cancer with poor prognosis is currently a major health problem in developing countries 1 . Exposure to occupational and environmental carcinogens and an individual's genetic background are some risk factors for pancreatic cancer 2–5 . Changes in redox metabolism in the metabolic reprogramming of nearly all cancers were associated with the accumulation of reactive oxygen species (ROS) 6 .…”

“… 1 Exposure to occupational and environmental carcinogens and an individual's genetic background are some risk factors for pancreatic cancer. 2 , 3 , 4 , 5 Changes in redox metabolism in the metabolic reprogramming of nearly all cancers were associated with the accumulation of reactive oxygen species (ROS). 6 ROS are free radicals that are an extremely dynamic material for cell damage and are produced during the transport of electrons from the mitochondria of living cells.…”

Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review

“…Very few studies explored the effectiveness of their proposed biomarkers in pre-diagnostic samples from asymptomatic patients. Although such samples are not readily available, these studies are essential for determining how early in the latency period the biomarkers can be detected [ 40 , 47 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 ]. Nolen et al [ 47 ] interrogated the large prospective Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial serum samples to detect eight biomarkers: CEA-related cell adhesion molecule 1 (CEACAM1) and prolactin (PRL) were detectable up to 35 months before PDAC diagnosis; CA19-9, carcinoembryonic antigen (CEA), neuron-specific enolase (NSE) and beta-human chorionic gonadotropin (b-HCG) up to 24 months; and CA125 and interleukin 8 (IL-8) up to 12 months prior PDAC diagnosis.…”

Myeloid‐derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma

“…During chronic inflammation, variety of pro‐inflammatory mediators (cytokines, cyclooxygenase‐2 (COX‐2) and reactive oxygen species [ROS]) are secreted by the pancreas, which leads to malignant transformation by promoting genomic damage to normal cells 8,21,22 . A prospective study performed on the Apolipoprotein‐related Mortality Risk cohort of Swedish residents has shown that chronic inflammation is associated with an increased risk of PC 5 . The production of pro‐angiogenic factors and matrix metalloproteases during chronic inflammation also helps in tumour neo‐vascularization, invasion and metastasis.…”

“…Numerous studies have found that chronic inflammation contributes to tumour initiation and progression, indicating that chronic pancreatitis is antecedent to PC 3‐5 . Chronic inflammation promotes tumour onset and development through non‐immune and immune mechanisms.…”